Comparing the Prognosis of Lactate-directed and Goal-directed Therapy in Hyperthermic Intraperitoneal Chemotherapy.
NCT ID: NCT03933930
Last Updated: 2020-06-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2019-05-06
2021-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Goal-Directed Fluid Therapy for Patients Undergoing Oro-Maxillofacial Surgery
NCT03086694
Preoperative Goal-directed Fluid Therapy and Physiological Changes Following One-lung Ventilation
NCT03064880
Goal Directed Therapy Aiming to Optimise Oxygen Central Venous Saturation in Children Undergoing Cardiac Surgery
NCT03469440
Goal-Directed Therapy in Cancer Surgery
NCT01946269
Goal-directed Intraoperative Fluid Therapy in High-risk Surgery
NCT02470221
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lactate-directed therapy
Lactate-directed therapy
If the lactate level elevates, we transfuse pRBC to increase Hct\>30%. If Hct \>30%, dopamine infusion starts.
Goal-directed therapy
If SVV\>15%, transfuse lactate ringer/normal saline alternatively to keep SVV\<15%.
Goal-directed therapy
Goal-directed therapy
If SVV\>15%, transfuse lactate ringer/normal saline alternatively to keep SVV\<15%.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lactate-directed therapy
If the lactate level elevates, we transfuse pRBC to increase Hct\>30%. If Hct \>30%, dopamine infusion starts.
Goal-directed therapy
If SVV\>15%, transfuse lactate ringer/normal saline alternatively to keep SVV\<15%.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taipei Medical University WanFang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
anchihhsu
Principal Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N201803039
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.